Skip to main content
Download PDF

Epidemiology, risk factors, clinical presentation and complications of late-onset neonatal sepsis among preterm neonates in Cyprus: a prospective case-control study

BMC Pediatrics volume 24, Article number: 50 (2024) Cite this article

Abstract

Background

Late-onset neonatal sepsis (LOS) is common in preterm neonates, with increasing incidence in recent years. In the present study, we examined the epidemiology, clinical presentation, and complications of LOS in Cyprus and quantified possible risk factors for the development of this condition.

Methods

The study subjects were preterm neonates admitted in the Neonatal Intensive Care Unit (NICU) of Archbishop Makarios III Hospital, the only neonatal tertiary centre in Cyprus. A prospective, case-control study was designed, and carried out between April 2017-October 2018. Depending on blood culture results, preterm neonates were classified as “Confirmed LOS”: positive blood culture - microorganism isolated and LOS symptoms, “Unconfirmed LOS”: negative blood culture and LOS symptoms, and “Controls” group: negative blood culture and absence of LOS symptoms. Comparisons between the 3 groups were performed and the associations between demographic, clinical and treatment characteristics with the likelihood of LOS were assessed using univariate and multivariate logistic regression.

Results

A total of 350 preterm neonates were included in the study and the incidence of LOS was 41.1%. 79 (22.6%) and 65 (18.6%) neonates were classified as “Confirmed LOS”, and “unconfirmed LOS” cases respectively while 206 (58.9%) served as controls. The rate of confirmed LOS ranged from 12.2% in moderate to late preterm neonates to 78.6% in extremely preterm neonates. In the multivariate model, we demonstrated an independent association between LOS and duration of hospitalization (OR: 1.06, 95%CI: 1.01–1.10), duration of ventilation (OR: 1.23, 95%CI: 1.07–1.43) and necrotising enterocolitis (OR: 3.41, 95%CI: 1.13–10.25).

Conclusions

The present study highlights the epidemiology of LOS in preterm neonates in Cyprus and its association with the duration of ventilation and hospitalization as well as with necrotizing enterocolitis. Establishment of protocols for the prevention of nosocomial infections during hospitalization in the NICUs and mechanical ventilation of preterm neonates is recommended.

Peer Review reports

Introduction

Neonatal sepsis is a clinical syndrome caused by pathogenic bacteria in the blood circulation and is characterized by hemodynamic changes and other systemic symptoms of infection. It may affect neonatal growth, result in organ failure and tissue damage, with implications for subsequent neurocognitive development and neonatal mortality [1]. The occurrence of neonatal bloodstream infection after the third day of life (> 72 h after birth) is defined as late-onset neonatal sepsis (LOS) and is a common complication in preterm neonates admitted to Neonatal Intensive Care Units (NICU) [2]. LOS is associated with poor prognosis accompanied by a prolonged hospital stay and significant morbidity and mortality, especially in preterm neonates with very low birth weight (VLBW) [3, 4].

Although incidence of LOS may vary among hospitalized neonates, increased survival of preterm and VLBW neonates has resulted in an overall increase of LOS incidence in recent years [5]. Invasive procedures employed in modern neonatal care are associated with higher risk of infection in this group of neonates [6], and previous studies highlighted placement of central venous catheters, prolonged mechanical ventilation, immunosuppression due to use of broad-spectrum antibiotics, necrotizing enterocolitis, patent ductus arteriosus and parenteral administration of nutrition as risk factors for LOS. [7,8,9,10]. Given the limited capacity of the developing immune system to mount an effective response to pathogens, which has been linked to increased neonatal susceptibility to infections [11], the mechanism of immunosuppression, caused by the use of broad-spectrum antibiotics, has been the focus of several studies. More specifically, early, and empirical antibiotic use has been found to result in detrimental effects on neonatal intestinal microbial diversity and richness, leading to intestinal dysbiosis [12, 13]. Based on a recent systematic review, these effects could range from acute to long-term, although additional evidence on the strength and duration of antibiotic-specific relationships with intestinal dysbiosis is needed [14]. Nevertheless, mounting evidence suggest that early-life acquisition of a dysbiotic intestinal microbiome predisposes to increased susceptibility to develop sepsis [15], emergence of resistance genes in the intestinal microbiome [16] and dysregulated immune responses [17].

A positive blood culture sets the diagnosis of LOS, and its incidence varies considerably across countries. In Australia, Canada, Greece, France and Finland, the incidence of LOS was estimated at 15.1%, 18.7%, 4.5%, 4.9% and 3.2%, respectively [18]. Although there are geographical differences in the distribution of pathogens isolated in blood cultures from preterm neonates with LOS in developed countries, gram-positive bacteria are the most common isolates with coagulase-negative staphylococci (CoNS) being the most common (> 30%) [5, 19]. Furthermore, the type of isolated pathogens is an independent prognostic factor for LOS in preterm neonates, with gram-negative bacteria demonstrating increased morbidity and mortality [20]. In an effort to better understand the epidemiology of neonatal infections, improve clinical practice and quality of care and establish better infection prevention strategies, several countries have set up national neonatal research networks for LOS [21,22,23].

Cyprus is an island with a population of around 1.216.000 people. The rate of caesarean section is 55.4% and of prematurity is 12%. Approximately, 65% of preterm neonates born in Cyprus require hospitalization in the NICU [24], but the frequency of LOS in the country remains unknown. To prevent or better manage of LOS in this resource limited setting, it is important to assess the frequency and complications of the condition as well as identify the prevailing prenatal, perinatal and postnatal risk factors for LOS in preterm infants. This approach may allow for earlier and more precise identification of LOS, leading to earlier and more targeted therapy with limited adverse events [25]. In this study, we examined the epidemiology of LOS in Cyprus, described the main clinical features and complications of neonates hospitalized with LOS in the country’s single neonatal tertiary care center and quantified the effect of possible risk factors for the development of LOS.

Materials and methods

Study population and study design

This was a prospective, case-control study conducted in the tertiary hospital ‘‘Archbishop Makarios III’’ [NAM III], which hosts the only level III NICU in Cyprus and cares for all preterm neonates in need of tertiary management in the country.

The study included all neonates with gestational age < 37 weeks, who were admitted in the NICU of NAM III between 1st April 2017 and 31st October 2018, and whose parents provided written informed consent to participate in the study. Participants were delivered either in the Obstetrics Department of NAM III, or in other public or private hospitals of the country and were then transferred to the NICU of NAM III for further management. Upon admission to the NICU, a blood culture was routinely performed in all neonates. If positive, a diagnosis of early neonatal infection (Early Onset Sepsis – EOS) was made and these were not included in the study population.

Based on the NAM III NICU clinical protocol, during hospitalization and upon clinical suspicion of bloodstream infection by the on-duty neonatologist, a blood culture was obtained, a lumbar puncture was performed (unless there are specific contraindications), and an empiric antibiotic treatment was initiated. Based on the results of blood cultures, preterm neonates were categorized into 2 separate groups, as in previous studies [4, 26,27,28,29,30,31,32]: (a) “Confirmed LOS” cases with positive blood culture - microorganism isolated at or after 72 h of life, LOS symptoms and who received blood culture-directed antibiotic therapy, (b) “Unconfirmed LOS” with clinical presentation of LOS and a negative blood culture taken at or after 72 h of life - no microorganism isolated. In the absence of international consensus on the definition of clinical LOS with negative blood culture in neonates [28, 29], we defined “Unconfirmed LOS” in the presence of all 4 of the subsequent criteria: [1] at least 2 of the following clinical signs and laboratory findings: rectal temperature > 380 C or < 360 C, leukocytosis or leukopenia, hypotension, bradycardia or tachycardia, or respiratory distress [shortness of breath or apnea], [2] absence of apparent infection at other site, [3] intake of antibiotics for at least 5 days and [4] no isolation of a microorganism in blood cultures [4, 30, 31]. A 3rd group of hospitalized preterm neonates served as “Controls” and included neonates without clinical symptoms suggestive of LOS and no confirmed infection in the blood culture routinely collected at time of NICU admission. Overall, we excluded from the study preterm neonates with early neonatal infection (positive blood culture during the first 72 h of life), congenital malformations, known chromosomal abnormalities, and infants with positive cultures of biological fluids other than peripheral blood. In addition, preterm neonates whose medical records had incomplete data of the above variables were also excluded from the study, as well as preterm neonates who died within the first 3 days of life. Lastly, preterm neonates with 2 microorganisms isolated in their blood culture, or if the microorganism was considered a microbiological contamination, were also excluded from the study [32].

Data collection

The socio-demographic and medical data of the mothers and the clinical data of the participating preterm neonates from birth to discharge, were collected from the hospital medical records and recorded in an electronic database. Collected data included maternal age, nationality, body mass index, and smoking habits, obstetric complications (preeclampsia, eclampsia, gestational hypertension, premature rupture of membranes, vaginal bleeding during pregnancy, placental abnormalities, gestational diabetes mellitus-GDM, chorioamnionitis, maternal thyroid disease, intrauterine growth restriction-IUGR), characteristics of pregnancy and delivery (single or multiple pregnancy, regular obstetric monitoring, parity, place and mode of delivery, prenatal steroid administration, gestational age, neonatal birth weight), perinatal characteristics (Apgar score, resuscitation in the delivery room, bronchopulmonary dysplasia-BPD, necrotizing enterocolitis-NEC, retinopathy of prematurity-ROP, respiratory distress syndrome-RDS), invasive or therapeutic interventions and duration of hospitalization. According to NAM III NICU clinical protocol, premature infants are discharged if they weigh ≧ 2 kg, have no abnormal clinical manifestations and are adequately bottle- or breast-fed.

Statistical analysis

Demographic and other characteristics of the mothers and newborns were presented as percentages in the case of categorical variables and medians (range) in the case of continuous variables. Comparisons between the 3 groups (LOS confirmed, LOS unconfirmed and Controls) were performed using Pearson’s Chi-squared test for categorical variables, Fisher’s exact test for continuous normally distributed variables and Kruskal-Wallis rank sum test for continuous non-normally distributed variables. The associations between demographic, clinical and treatment characteristics with LOS were assessed using univariate logistic regression. The dependent variable was binary and set as LOS positive status (LOS confirmed and LOS unconfirmed grouped together) or LOS negative status (controls). Multivariate logistic regression was performed including only the variables that were found to be statistically significant at pvalue <0.1 at the previous step. All analyses were performed using the statistical software R version 4.0.3. [33]

Results

364 preterm neonates were eligible for participation, and finally 350 were included in the study (96.2% participation rate). Among the 14 preterm neonates excluded, in 9 neonates the medical record was incomplete while in 5 parental consent was not obtained. A summary of the main maternal, perinatal, and postnatal characteristics of the study population is available in Table 1. Of the 350 neonates, 79 (22.6%) were classified as “confirmed LOS”, 65 (18.6%) as “unconfirmed LOS”, while the remaining 206 (58.8%) infants had no symptoms of LOS and were classified as “controls”. The frequency of “confirmed LOS” ranged from 10.9% in moderate to late preterm neonates (MLPT) to 78.6% in extremely pre-term (EPT) ones. Similarly, “confirmed LOS” was more frequent in preterm neonates of extremely low birthweight (ELBW) (70.6%), compared to preterm neonates with normal birthweight (9.4%). The most commonly isolated microorganism in the “confirmed LOS” group was CoNS (n = 72, 91.1%). The other microorganisms isolated were Candida species (n = 2), Enterococcus Faecalis (n = 2), Kocuria (n = 1), Sphingomonas paucimobilis (n = 1) and Escherichia coli (n = 1). There were no deaths in the participating neonates during hospitalization at the NICU.

Table 1 Participants characteristics (total sample, n = 350)
Full size table

Maternal, pregnancy and neonatal characteristics of the 3 groups

The distribution of maternal and pregnancy characteristics in the 3 groups is presented in Table 2. Maternal age and frequency of IUGR differed between the 3 groups; “LOS confirmed” neonates were characterized by higher maternal age and higher frequency of IUGR. The distribution of other maternal factors such as smoking and regular antenatal visits, as well as the distribution of other pregnancy complications including gestational diabetes, preeclampsia and thyroid disease during pregnancy were not significantly different between the 3 groups. Main neonatal characteristics such as gender, multiple birth status and mode of delivery were not statistically different between the 3 groups. However, a significant association between LOS and gestational age was observed, with EPT and VPT neonates demonstrating a higher risk of LOS (both confirmed and unconfirmed) in comparison to moderate to late preterm infants. Similar trends were also observed for birthweight, Apgar score (1st minute) and requirement for resuscitation at birth (Table 3).

Table 2 Perinatal variables, comparisons between the different categories
Full size table
Table 3 Postnatal variable characteristics analysis
Full size table

Treatment characteristics and complications of prematurity of the 3 groups

Treatment and hospitalization characteristics differed significantly between the 3 groups. More specifically, duration of hospitalization and duration of ventilation were longer in both LOS confirmed and LOS unconfirmed neonates compared to controls. Confirmed and unconfirmed LOS neonates were characterized by higher rates of transfusions, inotrope administration, as well as more frequent placement of umbilical and central line catheters. Complications of prematurity such as RDS, NEC, BPD and ROP were also more frequent in confirmed and unconfirmed LOS neonates compared to controls (Table 4).

Table 4 Hospitalization characteristics
Full size table

Association of risk factors and complications with LOS

To evaluate the direction and magnitude of the association between the examined risk factors and assessed complications with LOS, we grouped confirmed and unconfirmed LOS infants together and carried out univariate and multivariate logistic regression. In the univariate analysis, statistically significant associations with LOS were observed for gestational age, IUGR, Apgar score, resuscitation at birth, RDS, ventilation duration, use of catheters, transfusions, inotrope administration and duration of hospitalization (Table 5). In addition, LOS was significantly associated with NEC, ROP and BPD. All variables that were found to be significantly associated with LOS in the univariate analysis, were included as predictor variables in the multivariate model. An independent statistically significant relationship persisted only for duration of hospitalization, duration of ventilation, and NEC (Table 6).

Table 5 Univariate logistic regression results LOS confirmed and unconfirmed LOS are merged in one category and compared vs. controls:
Full size table
Table 6 Multivariate logistic regression results for LOS (LOS confirmed and unconfirmed LOS are merged in one category) vs. controls:
Full size table

Discussion

In this study, we report the frequency of LOS in premature neonates from the only one level 3 NICU in Cyprus, which covers the entire population of the Republic of Cyprus. In this population, the incidence of LOS was 41%, which is slightly higher than previously published estimates in Europe (20–38%) [26]. Our findings are in agreement with previous reports that demonstrated an association of LOS incidence in the NICU with birth weight and gestational age, ranging from 70% in very low birth weight (VLBW: ≤1500 g) neonates to 10.9% in MLPT (GA: 32–37 weeks) ones [34].

LOS in preterm neonates has important health and financial implications. Following nosocomial infections the duration of NICU hospitalisation of preterm neonates is increased, even with successful treatment [35, 36], thus increasing the financial cost of the overall inpatient care [37,38,39]. Our study showed that longer duration of mechanical ventilation is associated with increased risk of LOS, which is in-line with findings from similar studies and studies on ventilator associated pneumonia (VAP), an infection affecting intubated neonates [40, 41]. Characteristically, a recent study demonstrated that in neonates with VAP, the duration of mechanical ventilation was significantly longer compared to neonates without VAP, while the VAP mortality rate was estimated at 9% [42]. Similarly, newborns with RDS in mechanical ventilation have increased mortality, which may also be associated with LOS [43]. Introduction and diligent implementation of practices that reduce the frequency of LOS in NICU, especially in intubated neonates, are expected to lead to better clinical outcomes [44].

Other factors that may affect the frequency of LOS in preterm neonates include pregnancy complications and neonatal characteristics. Lower gestational age and lower birth weight were associated with increased risk in the univariate analysis as reported in previous studies [27, 45] and a recent meta-analysis focusing on recourse limited settings [46]. Although the survival of preterm neonates has increased over time, the rates of complications remain significant, with nosocomial infections [47] constituting an important primary cause of death after the first week of NICU hospitalization [48, 49]. Falciglia et al., have recently shown that infants with BW < 750 g have increased rates of RDS, NEC, cerebral hemorrhage, and infections [50]. To reduce the incidence of these complications, practices for prevention of premature delivery-especially the non-iatrogenic ones- are important. These strategies should aim at improving the socio-economic factors that affect prematurity, such as better nutrition of the pregnant woman and minimization of maternal stress [51, 52].

Evidently, increased survival rates of preterm neonates, led to a higher percentage of them receiving blood transfusions and invasive medical procedures during NICU hospitalization [53]. Latest evidence from two large clinical trials, show that the percentage of pre-term neonates (< 1000 g) receiving at least one transfusion during neonatal admission may be as high as 90%. Nevertheless, even in populations with similar characteristics and transfusion guidelines, considerable variability in this percentage may exist [54]. In our study, we did not observe an independent association of transfusions with blood products (concentrated erythrocytes, fresh frozen plasma and platelets) with higher risk of LOS. However, several previous studies have demonstrated this association in preterm neonates [55, 56]. Nevertheless, given that the most common cause of frozen plasma transfusion is infection, and the most common indication for platelet transfusion due to thrombocytopenia is prematurity and infection, [57, 58], transfusions with blood products will remain a frequent and sometimes necessary practice in pre-term neonates. However, there is strong evidence that this treatment method is not without complications [59,60,61,62,63] and a more restrictive transfusion strategy may limit unnecessary transfusions without increasing morbidity or mortality in this patient group [64,65,66]. Finally, this study showed a statistically significant independent association between LOS and NEC. NEC is a complication of multifactorial etiology including infections [67,68,69], and the association between LOS and NEC in preterm neonates is most likely attributed to the immaturity of their immune system and the resultant abnormal microbiota gut colonization [70, 71]. Given the strong relationship of both LOS and NEC with mortality and morbidity, more research efforts should be undertaken on the role of probiotics administration in NICU, a practice that is not currently implemented in Cyprus [72,73,74]. The potential cost effectiveness of this approach for preventing NEC is significant [75], although the choice of optimal probiotic strain and appropriate feeding type remains unclear [76].

Overall, our study benefited from prospective recruitment, prospective data collection and the high participation rate. In addition, as the NAM III hospital NICU is the only tertiary referral center in the country, with universal access of the population to its services, our study population is representative with no obvious limitations by socioeconomic or other criteria. Finally, as data collection relied on available data in patients’ files and as a result, recall and observed bias were avoided. Overall, these characteristics enhance the generalizability of our results. However, the study is characterized by some limitations, with the most important one being the high percentage of LOS attributed to CoNS. Although CoNS is a frequently identifiable LOS pathogen [77,78,79], it is also a common blood culture contaminant. For this reason, a laboratory–confirmed bloodstream infection for CoNS requires 2 or more blood cultures drawn on separate occasions according to CDC/NHSN guidelines [31], although this was not the practice in our NICU. Like in other settings, low blood volume and the need to start antibiotic therapy without delay, only rarely allow two blood cultures to be taken before treatment is initiated [79]. Although blood collection was carried out by competent staff using strict aseptic techniques, there is a possibility that some of the subjects were misclassified (i.e., included in the “Confirmed LOS” group, while these should have been classified as “Unconfirmed LOS”). Nevertheless, the descriptive comparisons between the two groups provide some evidence for important differences in certain perinatal, postnatal and hospitalization characteristics between the “Confirmed LOS” and “Unconfirmed LOS” subjects. In addition, the main findings of this study, on the associations between demographic, clinical and treatment characteristics with LOS, emerged from the comparison of the “Controls” group as the LOS negative status with the “Confirmed LOS” and “Unconfirmed LOS” grouped together as the LOS positive status. As a result, any misclassification between the two LOS categories did not influence the main study findings. An additional limitation is the employed cross-sectional study design, as it was able to assess only short-term clinical outcomes and couldn’t examine the association of LOS with long-term health outcomes. Furthermore, the study did not systematically collect data on non-sepsis infections such as ventilator associated pneumonia, that would allow us to define a concurrent focus of infection that may have progressed to LOS [7]. As a result, we couldn’t include the distribution of ventilator associated pneumonia or other infectious foci as an additional factor in the multivariate analysis. In addition, although participation rate was high and the risk for selection bias is limited, the overall low sample size did not allow for the evaluation of rare outcomes. Finally, our study was restricted to LOS cases among preterm neonates and for an observation period of 18 months. Further studies, employing appropriate methodology and spanning to all suspected LOS cases and for a longer observation period, are required to fully describe the epidemiology and microbiology of LOS in Cyprus.

Conclusions

In summary, the present study highlights the epidemiology of LOS in preterm neonates in Cyprus, identifies possible risk factors and associated clinical characteristics, and complications. For the prevention of LOS, establishment of protocols for the prevention of nosocomial infections during hospitalization in the NICUs and mechanical ventilation of preterm neonates is recommended.

Data Availability

All data generated or analysed during this study are included in this published article (Supplementary file 1).

References

  1. Shuai X, Li X, Wu Y. Prediction for late-onset sepsis in preterm infants based on data from East China. Front Pead 2022, 10.

  2. Dong Y, Speer CP. Late-onset neonatal sepsis: recent developments. Arch Dis Child Fetal Neonatal Ed. 2015;100(3):257.

    Article  Google Scholar 

  3. Tsai M, Chu S, Lee C, Hsu J, Huang H, Chiang M, Fu R, Lien R, Huang Y. Recurrent late-onset sepsis in the neonatal intensive care unit: incidence, clinical characteristics and risk factors. Clin Microbiol Infect. 2014;20(11):O928–35.

    Article  PubMed  Google Scholar 

  4. Rand KM, Austin NC, Inder TE, Bora S, Woodward LJ. Neonatal Infection and later neurodevelopmental risk in the very preterm infant. J Pediatr. 2016;170:97–104.

    Article  PubMed  Google Scholar 

  5. Shah J, Jefferies AL, Yoon EW, Lee SK, Shah PS. Canadian neonatal network: risk factors and outcomes of late-onset bacterial sepsis in preterm neonates born at < 32 weeks’ gestation. Am J Perinatol. 2015;32(07):675–82.

    PubMed  Google Scholar 

  6. Dal-Bó K, Silva RMd, Sakae TM. Nosocomial Infections in a neonatal intensive care unit in South Brazil. Revista Brasileira De Terapia Intensiva. 2012;24:381–5.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Wu I, Tsai M, Lai M, Hsu L, Chiang M, Lien R, Fu R, Huang H, Chu S, Hsu J. Incidence, clinical features, and implications on outcomes of neonatal late-onset sepsis with concurrent infectious focus. BMC Infect Dis. 2017;17(1):465.

    Article  PubMed  PubMed Central  Google Scholar 

  8. Hassani EME, Berkhout S, Niemarkt DJC, Mann HJ, de Boode S, Cossey WP, Hulzebos V, van Kaam CV, Kramer AH, van Lingen BW, van Goudoever RA, Vijlbrief JB, van Weissenbruch DC, Benninga MM, de Boer MA, de Meij NKH. Risk factors for late-onset Sepsis in Preterm infants: a Multicenter Case-Control Study. Neonatology. 2019;116(1):42–51.

    Article  Google Scholar 

  9. Resende DS, Peppe ALG, Reis Hd, Abdallah VOS, Ribas RM, Gontijo PP. Late onset sepsis in newborn babies: epidemiology and effect of a bundle to prevent central line associated bloodstream Infections in the neonatal intensive care unit. Brazilian J Infect Dis. 2015;19:52–7.

    Article  Google Scholar 

  10. Legeay C, Bourigault C, Lepelletier D, Zahar JR. Prevention of healthcare-associated Infections in neonates: room for improvement. J Hosp Infect. 2015;89(4):319–23.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Zhang X, Zhivaki D, Lo-Man R. Unique aspects of the perinatal immune system. Nat Rev Immunol. 2017;17(8):495–507.

    Article  PubMed  CAS  Google Scholar 

  12. Dardas M, Gill SR, Grier A, Pryhuber GS, Gill AL, Lee Y, Guillet R. The impact of postnatal antibiotics on the preterm intestinal microbiome. Pediatr Res. 2014;76(2):150–8.

    Article  PubMed  CAS  Google Scholar 

  13. Greenwood C, Morrow AL, Lagomarcino AJ, Altaye M, Taft DH, Yu Z, Newburg DS, Ward DV, Schibler KR. Early empiric antibiotic use in preterm infants is associated with lower bacterial diversity and higher relative abundance of Enterobacter. J Pediatr. 2014;165(1):23–9.

    Article  PubMed  PubMed Central  Google Scholar 

  14. McDonnell L, Gilkes A, Ashworth M, Rowland V, Harries TH, Armstrong D, White P. Association between antibiotics and gut microbiome dysbiosis in children: systematic review and meta-analysis. Gut Microbes. 2021;13(1):1870402.

    Article  PubMed  PubMed Central  Google Scholar 

  15. Kullberg RF, Wiersinga WJ, Haak BW. Gut microbiota and sepsis: from pathogenesis to novel treatments. Curr Opin Gastroenterol. 2021;37(6):578–85.

    Article  PubMed  CAS  Google Scholar 

  16. Tapiainen T, Koivusaari P, Brinkac L, Lorenzi HA, Salo J, Renko M, Pruikkonen H, Pokka T, Li W, Nelson K. Impact of intrapartum and postnatal antibiotics on the gut microbiome and emergence of antimicrobial resistance in infants. Sci Rep. 2019;9(1):1–11.

    Article  CAS  Google Scholar 

  17. Zhang X, Borbet TC, Fallegger A, Wipperman MF, Blaser MJ, Müller A. An antibiotic-impacted microbiota compromises the development of colonic regulatory T cells and predisposes to dysregulated immune responses. Mbio. 2021;12(1):3335.

    Article  Google Scholar 

  18. Wójkowska-Mach J, Chmielarczyk A, Strus M, Lauterbach R, Heczko P. Neonate bloodstream Infections in organization for economic cooperation and development countries: an update on epidemiology and prevention. J Clin Med. 2019;8(10):1750.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Cortese F, Scicchitano P, Gesualdo M, Filaninno A, De Giorgi E, Schettini F, Laforgia N, Ciccone MM. Early and late Infections in newborns: where do we stand? A review. Pediatr Neonatology. 2016;57(4):265–73.

    Article  Google Scholar 

  20. Shehab El-Din EMR, El-Sokkary MMA, Bassiouny MR, Hassan R. Epidemiology of neonatal sepsis and implicated pathogens: a study from Egypt. BioMed research international 2015, 2015.

  21. Vergnano S, Menson E, Kennea N, Embleton N, Russell AB, Watts T, Robinson MJ, Collinson A, Heath PT. Neonatal Infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed. 2011;96(1):F9–F14.

    Article  PubMed  Google Scholar 

  22. Daley AJ, Isaacs D, Australasian Study Group for Neonatal Infections. Ten-year study on the effect of intrapartum antibiotic prophylaxis on early onset group B streptococcal and Escherichia coli neonatal sepsis in Australasia. Pediatr Infect Dis J. 2004;23(7):630–4.

    Article  PubMed  Google Scholar 

  23. Colomer BF, Badia MC, Cotallo DC, Sastre JL, Network GC. The Spanish National Network Grupo Castrillo: 22 years of nationwide neonatal Infection surveillance. Am J Perinatol. 2020;37(S 02):71–S75.

    Google Scholar 

  24. Kyprianou T. Perinatal health indicators, Cyprus public and private maternity units 2014–2016. 2018.

  25. Coggins SA, Glaser K. Updates in Late-Onset Sepsis: Risk Assessment, Therapy, and Outcomes. NeoReviews 2022, 23(11):738–755.

  26. El Hassani SEM, Berkhout DJ, Niemarkt HJ, Mann S, De Boode WP, Cossey V, Hulzebos CV, Van Kaam AH, Kramer BW, van Lingen RA. Risk factors for late-onset sepsis in preterm infants: a multicenter case-control study. Neonatology. 2019;116(1):42–51.

    Article  Google Scholar 

  27. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, Lemons JA, Donovan EF, Stark AR, Tyson JE. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics. 2002;110(2):285–91.

    Article  PubMed  Google Scholar 

  28. Wynn JL. Defining neonatal sepsis. Curr Opin Pediatr. 2016;28(2):135.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Wagstaff JS, Durrant RJ, Newman MG, Eason R, Ward RM, Sherwin CM, Enioutina EY. Antibiotic treatment of suspected and confirmed neonatal sepsis within 28 days of birth: a retrospective analysis. Frontiers in pharmacology 2019,:1191.

  30. Goldstein B, Giroir B, Randolph A. International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6(1):2–8.

    Article  PubMed  Google Scholar 

  31. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of health care–associated Infection and criteria for specific types of Infections in the acute care setting. Am J Infect Control. 2008;36(5):309–32.

    Article  PubMed  Google Scholar 

  32. Berardi A, Sforza F, Baroni L, Spada C, Ambretti S, Biasucci G, Bolognesi S, Capretti M, Carretto E, Ciccia M. Epidemiology and Complications of late-onset sepsis: an Italian area-based study. PLoS ONE. 2019;14(11):e0225407.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  33. Team RC. R: A language and environment for statistical computing. 2013.

  34. Tsai M, Hsu J, Chu S, Lien R, Huang H, Chiang M, Fu R, Lee C, Huang Y. Incidence, clinical characteristics and risk factors for adverse outcome in neonates with late-onset sepsis. Pediatr Infect Dis J. 2014;33(1):e7–e13.

    Article  PubMed  Google Scholar 

  35. Różańska A, Wójkowska-Mach J, Adamski P, Borszewska-Kornacka M, Gulczyńska E, Nowiczewski M, Helwich E, Kordek A, Pawlik D, Bulanda M. Infections and risk-adjusted length of stay and hospital mortality in Polish neonatology Intensive Care Units. Int J Infect Dis. 2015;35:87–92.

    Article  PubMed  Google Scholar 

  36. Michael Cotten C, Oh W, McDonald S, Carlo W, Fanaroff AA, Duara S, Stoll B, Laptook A, Poole K, Wright LL. Prolonged hospital stay for extremely premature infants: risk factors, center differences, and the impact of mortality on selecting a best-performing center. J Perinatol. 2005;25(10):650–5.

    Article  PubMed  Google Scholar 

  37. Stevens W, Shih T, Incerti D, Ton TG, Lee HC, Peneva D, Macones GA, Sibai BM, Jena AB. Short-term costs of preeclampsia to the United States health care system. Obstet Gynecol. 2017;217(3):237–48. e16.

    Google Scholar 

  38. Fenny AP, Otieku E, Labi KA, Asante FA, Enemark U. Costs and extra length of stay because of neonatal bloodstream Infection at a teaching hospital in Ghana. PharmacoEconomics-Open. 2021;5(1):111–20.

    Article  PubMed  Google Scholar 

  39. Sahiledengle B, Tekalegn Y, Zenbaba D, Woldeyohannes D, Teferu Z. Which factors predict hospital length-of-stay for children admitted to the neonatal intensive care unit and pediatric ward? A hospital-based prospective study. Global Pediatr Health. 2020;7:2333794X20968715.

    Article  Google Scholar 

  40. Kawanishi F, Yoshinaga M, Morita M, Shibata Y, Yamada T, Ooi Y, Ukimura A. Risk factors for ventilator-associated Pneumonia in neonatal intensive care unit patients. J Infect Chemother. 2014;20(10):627–30.

    Article  PubMed  Google Scholar 

  41. Choi Y, Lee J, Park J, Jun YH. Impact of prolonged mechanical ventilation in very low birth weight infants: results from a national cohort study. J Pediatr. 2018;194:34–9. e3.

    Article  PubMed  Google Scholar 

  42. Rangelova VR, Raycheva RD, Kevorkyan AK, Krasteva MB, Kalchev YI. Ventilator-Associated Pneumonia in neonates admitted to a Tertiary Care NICU in Bulgaria. Front Pediatr. 2022;10:909217.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Iqbal Q, Younus MM, Ahmed A, Ahmad I, Iqbal J, Charoo BA, Ali SW. Neonatal mechanical ventilation: indications and outcome. Indian J Crit care Medicine: peer-reviewed Official Publication Indian Soc Crit Care Med. 2015;19(9):523.

    Article  CAS  Google Scholar 

  44. Ramirez P, Bassi GL, Torres A. Measures to prevent nosocomial Infections during mechanical ventilation. Curr Opin Crit Care. 2012;18(1):86–92.

    Article  PubMed  Google Scholar 

  45. Makhoul IR, Sujov P, Smolkin T, Lusky A, Reichman B. Israel Neonatal Network: Epidemiological, clinical, and microbiological characteristics of late-onset sepsis among very low birth weight infants in Israel: a national survey. Pediatrics. 2002;109(1):34–9.

    Article  PubMed  Google Scholar 

  46. Bech CM, Stensgaard CN, Lund S, Holm-Hansen C, Brok JS, Nygaard U, Poulsen A. Risk factors for neonatal sepsis in Sub-saharan Africa: a systematic review with meta-analysis. BMJ open. 2022;12(9):e054491.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Glass HC, Costarino AT, Stayer SA, Brett C, Cladis F, Davis PJ. Outcomes for extremely premature infants. Anesth Analg. 2015;120(6):1337.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Andegiorgish AK, Andemariam M, Temesghen S, Ogbai L, Ogbe Z, Zeng L. Neonatal mortality and associated factors in the specialized neonatal care unit Asmara, Eritrea. BMC Public Health. 2020;20(1):1–9.

    Article  Google Scholar 

  49. Tewabe T, Mehariw Y, Negatie E, Yibeltal B. Neonatal mortality in the case of Felege Hiwot referral hospital, Bahir Dar, Amhara Regional State, North West Ethiopia 2016: a one year retrospective chart review. Ital J Pediatr. 2018;44(1):1–5.

    Article  Google Scholar 

  50. Falciglia HS, Merkel RC, Glover V, Hasselfeld KA, Brady WK. The mortality of periviable and extremely premature infants and their impact on the overall neonatal mortality rate. Sci Rep. 2020;10(1):1–7.

    Article  Google Scholar 

  51. Newnham JP, Dickinson JE, Hart RJ, Pennell CE, Arrese CA, Keelan JA. Strategies to prevent preterm birth. Front Immunol. 2014;5:584.

    Article  PubMed  PubMed Central  Google Scholar 

  52. Stylianou-Riga P, Kouis P, Kinni P, Rigas A, Papadouri T, Yiallouros PK, Theodorou M. Maternal socioeconomic factors and the risk of premature birth and low birth weight in Cyprus: a case–control study. Reproductive Health. 2018;15(1):1–8.

    Article  Google Scholar 

  53. Howarth C, Banerjee J, Aladangady N. Red blood cell transfusion in Preterm infants: current evidence and controversies. Neonatology. 2018;114(1):7–16.

    Article  PubMed  Google Scholar 

  54. Meyer MP, O’Connor KL, Meyer JH. Thresholds for blood transfusion in extremely preterm infants: a review of the latest evidence from two large clinical trials. Front Pead. 2022;10:957585.

    Article  Google Scholar 

  55. dos Santos AMN, Guinsburg R, de Almeida MFB, Procianoy RS, Marba STM, Ferri WAG, Rugolo LMS, Lopes JMA, Moreira MEL, Luz JH. Factors associated with red blood cell transfusions in very-low-birth-weight preterm infants in Brazilian neonatal units. BMC Pediatr. 2015;15(1):1–8.

    Google Scholar 

  56. Shanmugha Priya RA, Krishnamoorthy R, Panicker VK, Ninan B. Transfusion support in preterm neonates. Asian J Transfus Sci. 2018;12(1):34–41.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  57. Resch E, Hinkas O, Urlesberger B, Resch B. Neonatal thrombocytopenia—causes and outcomes following platelet transfusions. Eur J Pediatr. 2018;177(7):1045–52.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Amrutiya RJ, Mungala BM, Patel VT, Ganjiwale JD, Nimbalkar SM. Blood component transfusion in Tertiary Care neonatal intensive care unit and neonatal Intermediate Care Unit: an audit. Cureus 2020, 12(8).

  59. Mally P, Golombek SG, Mishra R, Nigam S, Mohandas K, Depalhma H, LaGamma EF. Association of necrotizing enterocolitis with elective packed red blood cell transfusions in stable, growing, premature neonates. Am J Perinatol. 2006;23(08):451–8.

    Article  PubMed  Google Scholar 

  60. Slidsborg C, Jensen A, Forman JL, Rasmussen S, Bangsgaard R, Fledelius HC, Greisen G, la Cour M. Neonatal risk factors for treatment-demanding retinopathy of prematurity: a Danish national study. Ophthalmology. 2016;123(4):796–803.

    Article  PubMed  Google Scholar 

  61. Baer VL, Lambert DK, Henry E, Snow GL, Butler A, Christensen RD. Among very-low‐birth‐weight neonates is red blood cell transfusion an Independent risk factor for subsequently developing a severe intraventricular Hemorrhage? Transfusion 2011, 51(6):1170–8.

  62. Ghirardello S, Dusi E, Cortinovis I, Villa S, Fumagalli M, Agosti M, Milani S, Mosca F. Effects of red blood cell transfusions on the risk of developing Complications or death: an observational study of a cohort of very low birth weight infants. Am J Perinatol. 2017;34(01):88–95.

    PubMed  Google Scholar 

  63. dos Santos AMN, Guinsburg R, de Almeida MFB, Procianoy RS, Leone CR, Marba STM, de Souza Rugolo LMS, Fiori HH, de Andrade Lopes JM, Martinez FE. Red blood cell transfusions are independently associated with intra-hospital mortality in very low birth weight preterm infants. J Pediatr. 2011;159(3):371–6. e3.

    Article  PubMed  Google Scholar 

  64. Heeger LE, Counsilman CE, Bekker V, Bergman KA, Zwaginga JJ, Te Pas AB, Lopriore E. Restrictive guideline for red blood cell transfusions in preterm neonates: effect of a protocol change. Vox Sang. 2019;114(1):57–62.

    Article  PubMed  Google Scholar 

  65. Knee D, Knoop S, Davis AT, Rawson B, DiCarlo A, Olivero R. Outcomes after implementing restrictive blood transfusion criteria in extremely premature infants. J Perinatol. 2019;39(8):1089–97.

    Article  PubMed  Google Scholar 

  66. Wang P, Wang X, Deng H, Li L, Chong W, Hai Y, Zhang Y. Restrictive versus Liberal transfusion thresholds in very low birth weight infants: a systematic review with meta-analysis. PLoS ONE. 2021;16(8):e0256810.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  67. Gephart MSM, McGrath JM, Effken JA, Halpern MD. Necrotizing enterocolitis risk: state of the science. Adv Neonatal Care. 2012;12(2):77.

    Article  PubMed  PubMed Central  Google Scholar 

  68. Neu J, Walker WA. Necrotizing enterocolitis. N Engl J Med. 2011;364(3):255–64.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  69. Samuels N, van de Graaf RA, de Jonge RC, Reiss IK, Vermeulen MJ. Risk factors for necrotizing enterocolitis in neonates: a systematic review of prognostic studies. BMC Pediatr. 2017;17(1):1–9.

    Article  Google Scholar 

  70. Neu J. Necrotizing enterocolitis: the mystery goes on. Neonatology. 2014;106(4):289–95.

    Article  PubMed  CAS  Google Scholar 

  71. Unger S, Stintzi A, Shah P, Mack D, O’Connor DL. Gut microbiota of the very-low-birth-weight infant. Pediatr Res. 2015;77(1):205–13.

    Article  PubMed  Google Scholar 

  72. AlFaleh K, Anabrees J. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Evidence-Based Child Health: A Cochrane Review Journal. 2014;9(3):584–671.

    Article  PubMed  Google Scholar 

  73. Jacobs SE, Tobin JM, Opie GF, Donath S, Tabrizi SN, Pirotta M, Morley CJ, Garland SM, ProPrems Study Group. Probiotic effects on late-onset sepsis in very preterm infants: a randomized controlled trial. Pediatrics. 2013;132(6):1055–62.

    Article  PubMed  Google Scholar 

  74. Zhang G, Hu H, Liu C, Shakya S, Li Z. Probiotics for preventing late-onset sepsis in preterm neonates: a PRISMA-compliant systematic review and meta-analysis of randomized controlled trials. Medicine 2016, 95(8).

  75. Craighead AF, Caughey AB, Chaudhuri A, Yieh L, Hersh AR, Dukhovny D. Cost-effectiveness of probiotics for necrotizing enterocolitis prevention in very low birth weight infants. J Perinatol. 2020;40(11):1652–61.

    Article  PubMed  Google Scholar 

  76. Beghetti I, Panizza D, Lenzi J, Gori D, Martini S, Corvaglia L, Aceti A. Probiotics for preventing necrotizing enterocolitis in preterm infants: a network meta-analysis. Nutrients. 2021;13(1):192.

    Article  PubMed  PubMed Central  Google Scholar 

  77. Dong Y, Speer CP. Late-onset neonatal sepsis: recent developments. Archives of Disease in Childhood-Fetal and Neonatal Edition. 2015;100(3):F257–63.

    Article  PubMed  Google Scholar 

  78. Dillenseger L, Langlet C, Iacobelli S, Lavaux T, Ratomponirina C, Labenne M, Astruc D, Severac F, Gouyon JB, Kuhn P. Early inflammatory markers for the diagnosis of late-onset sepsis in neonates: the nosodiag study. Front Pead. 2018;6:346.

    Article  Google Scholar 

  79. Bury G, Leroux S, Leon Borrego C, Gras Leguen C, Mitanchez D, Gascoin G, Thollot A, Roué JM, Carrault G, Pladys P. Diagnosis of neonatal late-onset Infection in very preterm infant: inter-observer agreement and international classifications. Int J Environ Res Public Health. 2021;18(3):882.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors are grateful to all participants for their involvement in the study and would also like to acknowledge support by Ms Evelyn Charalambous in proofreading and revising the manuscript for correctness of English language use.

Funding

Open access funding provided by the Cyprus Libraries Consortium (CLC).

Author information

Authors and Affiliations

  1. Neonatal Intensive Care Unit, “Archbishop Makarios III” Hospital, Nicosia, Cyprus

    Paraskevi Stylianou-Riga

  2. Respiratory Physiology Laboratory, Medical School, University of Cyprus Shakolas Educational Center of Clinical, Medicine Palaios Dromos Lefkosias Lemesou 215/6, Aglantzia, Nicosia, 2029, Cyprus

    Paraskevi Stylianou-Riga, Panayiotis Kouis, Paraskevi Kinni, Constantinos Pitsios & Panayiotis K. Yiallouros

  3. Neonatal Department, Medical School, Aretaieio Hospital, National and Kapodistrian University of Athens, Athens, Greece

    Paraskevi Stylianou-Riga, Theodora Boutsikou, Rozeta Sokou, Zoi Iliodromiti & Nicoletta Iacovidou

  4. Biostatistics Unit, Institute of Neurology and Genetics, Nicosia, Cyprus

    Kyriaki Michailidou

Authors
  1. Paraskevi Stylianou-Riga
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Theodora Boutsikou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Panayiotis Kouis
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kyriaki Michailidou
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Paraskevi Kinni
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Rozeta Sokou
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zoi Iliodromiti
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Constantinos Pitsios
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Panayiotis K. Yiallouros
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Nicoletta Iacovidou
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

P.S.R. and N.I. devised the study hypothesis and were responsible for the project implementation. T.B. and P.K.Y. contributed to the study hypothesis and advised on the study design. P.S.R., P.K., K.P., R.S., Z.I and C.P. participated in data collection and prepared the study dataset. K.M. performed the statistical analysis and P.S.R., P.K. and T.B. drafted the first version of the manuscript. All authors have read, revised, and approved the final version of the manuscript.

Corresponding author

Correspondence to Paraskevi Stylianou-Riga.

Ethics declarations

Ethics approval and consent to participate

The study protocol was reviewed and approved by the Cyprus National Bioethics Committee (EEBK EΠ 2017.01.22). All study procedures were conducted in accordance with relevant guidelines and regulations. Parents of each subject provided a written informed consent prior participation in the study.

Consent for publication

Not applicable.

Competing interests

The authors have no conflicts of interest to declare.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Stylianou-Riga, P., Boutsikou, T., Kouis, P. et al. Epidemiology, risk factors, clinical presentation and complications of late-onset neonatal sepsis among preterm neonates in Cyprus: a prospective case-control study. BMC Pediatr 24, 50 (2024). https://doi.org/10.1186/s12887-023-04359-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12887-023-04359-6

BMC Pediatrics

ISSN: 1471-2431

Contact us